Back to Peptides
ApprovedApproved (Ozempic)
Semaglutide for Sarcopenia
Semaglutide may help with Sarcopenia through its GHRH agonist mechanisms, potentially supporting weight loss.
About Sarcopenia
Sarcopenia is a age-related condition characterized by muscle loss and weakness. Conventional treatments include exercise, protein supplementation.
Common Symptoms
muscle lossweaknessreduced mobility
Conventional Treatments
- exercise
- protein supplementation
- HRT
How Semaglutide May Help
Semaglutide works through GLP-1 agonist to support weight loss. Current research status: Approved.
Mechanisms of Action
GLP-1 agonist
Potential Benefits
- weight loss
- blood sugar control
- cardiovascular benefits
Research Status & Legal Information
Research Status
Approved
Legal Status (Australia)
Approved (Ozempic)
Medical Disclaimer
This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare practitioner before starting any peptide therapy.
Potential Side Effects
- nausea
- vomiting
- diarrhea